Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
20 hedge funds and large institutions have $4.14M invested in Biocept, Inc. in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
40% more capital invested
Capital invested by funds: $2.95M → $4.14M (+$1.19M)
18% more funds holding
Funds holding: 17 → 20 (+3)
9.03% more ownership
Funds ownership: 7.93% → 16.96% (+9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.2M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$925K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$846K |
| 4 |
VF
Virtu Financial
New York
|
+$71.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$63.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$52K |
| 2 |
Millennium Management
New York
|
-$28K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$18K |
| 4 |
Morgan Stanley
New York
|
-$12K |
| 5 |
GBA
Garrison Bradford & Associates
New York
|
-$7.91K |
BIOC Hedge Fund Activity: Q4 2017 in Review
20 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q4 2017, worth a combined $4.14M — up 40% from $2.95M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new BIOC positions and 4 closed out — a net gain of 3 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.2M. The largest seller was Bank of Montreal, exiting entirely with an estimated $52K sold.
- 20 institutional investors held Biocept, Inc. (BIOC) as of Q4 2017, up from 17 in Q3 2017.
- Funds reported $4.14M of Biocept, Inc. stock for Q4 2017, up 40% quarter-over-quarter.
- 7 funds opened new Biocept, Inc. positions in Q4 2017 and 4 closed out, a net change of +3 holders.
- The largest Biocept, Inc. buyer in Q4 2017 was Susquehanna International Group, an estimated $1.2M added.
- The largest Biocept, Inc. seller in Q4 2017 was Bank of Montreal, an estimated $52K sold.
Based on aggregated 13F filings for Q4 2017.